SCHEMBL4282847

SCHEMBL4282847

CCOc1ccc(C(=O)c2c(F)cc(C)cc2OC(C)=O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
ALDH1A1 P00352 2/20 0.45
PARP10 Q53GL7 1/20 0.43
MAOB P27338 2/20 0.43
MAPK1 P28482 2/20 0.43
LMNA P02545 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CHRNB2 P17787 1/20 0.43
CHRNB4 P30926 1/20 0.43
CHRNA3 P32297 1/20 0.43
CHRNA4 P43681 1/20 0.43
MAPT P10636 4/20 0.42
KDM4E B2RXH2 3/20 0.42
ALOX15 P16050 2/20 0.42
NPC1 O15118 4/20 0.42
RAB9A P51151 3/20 0.42
HPGD P15428 2/20 0.42
RECQL P46063 1/20 0.42
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4286723 0.90 L3MBTL1 (0.44) KMT2AALDH1A1MAPK1LMNAL3MBTL1
SCHEMBL4282990 0.87 MAPT (0.46) KMT2ANPSR1ALDH1A1PARP10MAPK1
SCHEMBL4287208 0.85 BACE1 (0.49) KMT2ANPSR1ALDH1A1MAPK1LMNA
SCHEMBL4292209 0.83 MAPT (0.51) KMT2ANPSR1ALDH1A1PARP10MAOB
SCHEMBL4284608 0.82 KMT2A (0.44) KMT2ANPSR1ALDH1A1PARP10MAPK1
SCHEMBL4280964 0.73 SLC5A1 (0.47) ALDH1A1PARP10MAPK1LMNAL3MBTL1
SCHEMBL4281349 0.72 KMT2A (0.57) KMT2ANPSR1ALDH1A1MAPK1LMNA
SCHEMBL30776959 0.72 KMT2A (0.69) KMT2ANPSR1ALDH1A1PARP10MAOB
SCHEMBL4289278 0.72 MAPT (0.51) KMT2ANPSR1ALDH1A1PARP10MAPK1
SCHEMBL4285255 0.72 HPGD (0.50) KMT2ANPSR1ALDH1A1MAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-05-28 US disclosed
EP-2048150-A1 BENZYL PHENYL GLUCOPYRANOSIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-04-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137499-A1 BENZYLPHENYL GLUCOPYRANOSIDE DERIVATIVE SLC5A1, SLC5A2, SLC2A1 KMT2A 1397/4885NPSR1 1569/4885ALDH1A1 896/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.